Details

Autor(en) / Beteiligte

• Konuma, Takaaki
• Mizuno, Shohei
• Kondo, Tadakazu
• Arai, Yasuyuki
• Uchida, Naoyuki
• Takahashi, Satoshi
• Tanaka, Masatsugu
• Kuriyama, Takuro
• Miyakoshi, Shigesaburo
• Onizuka, Makoto
• Ota, Shuichi
• Sugio, Yasuhiro
• Kouzai, Yasushi
• Kawakita, Toshiro
• Kobayashi, Hikaru
• Ozawa, Yukiyasu
• Kimura, Takafumi
• Ichinohe, Tatsuo
• Atsuta, Yoshiko
• Yanada, Masamitsu

Titel

Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia

Ist Teil von

• Blood cancer journal (New York), 2022-05, Vol.12 (5), p.81-81, Article 81

Ort / Verlag

London: Nature Publishing Group UK

Erscheinungsjahr

2022

Quelle

Electronic Journals Library

Beschreibungen/Notizen

• Unrelated cord blood transplantation (CBT) is an alternative curative option for adult patients with acute myeloid leukemia (AML) who need allogeneic hematopoietic cell transplantation (HCT) but lack an HLA-matched related or unrelated donor. However, large-scale data are lacking on CBT outcomes for unselected adult AML. To investigate the trends of survival and engraftment after CBT over the past 22 years, we retrospectively evaluated the data of patients with AML in Japan according to the time period of CBT (1998–2007 vs 2008–2013 vs 2014–2019). A total of 5504 patients who received single-unit CBT as first allogeneic HCT for AML were included. Overall survival (OS) at 2 years significantly improved over time. The improved OS among patients in ≥ complete remission (CR)3 and active disease at CBT was mainly due to a reduction of relapse-related mortality, whereas among patients in first or second CR at CBT, this was due mainly to a reduction of non-relapse mortality. The trends of neutrophil engraftment also improved over time. This experience demonstrated that the survival and engraftment rate after CBT for this group has improved over the past 22 years.